A 12-year consultant who lead projects for companies such as Merck Pharmaceuticals, Microsoft, Kaplan, and Vitas Hospice. He currently leads and manages the vision for RevGenetics in its aims to combat aging through gene activation. "I have seen the pain and toll that a loved one in hospice care produces. RevGenetics was created to help find a way to help limit that experience as much as possible. We fund this ongoing research by providing the public some of the best gene-activating molecules tested. We do this research for your family as well as for ours." - Anthony Loera
There are no posts.